$60,000 of EXACT SCIENCES CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 2085, the Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S. 2085, the Medicare Multi-Cancer Early Detection Screening Coverage Act Finn Sawyer Access to Cancer Testing Act (H.R. 1780 / S. 642) Access to Genetic Counselor Services Act (H.R. 3876 / S. 2323) FY25 MilCon appropriations Access to colorectal cancer screening tests"
You can find more data on corporate lobbying on Quiver Quantitative.
EXAS Insider Trading Activity
EXAS insiders have traded $EXAS stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $EXAS stock by insiders over the last 6 months:
- KEVIN T CONROY (President and CEO) purchased 19,500 shares for an estimated $1,001,325
- BRIAN BARANICK (EVP, GM, Precision Oncology) has made 0 purchases and 2 sales selling 1,858 shares for an estimated $130,060.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EXAS Hedge Fund Activity
We have seen 269 institutional investors add shares of EXAS stock to their portfolio, and 259 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 8,024,431 shares (+58.9%) to their portfolio in Q3 2024, for an estimated $546,624,239
- AMERIPRISE FINANCIAL INC added 2,310,704 shares (+104.3%) to their portfolio in Q3 2024, for an estimated $157,405,156
- HOLOCENE ADVISORS, LP removed 2,169,207 shares (-53.7%) from their portfolio in Q3 2024, for an estimated $147,766,380
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,112,953 shares (+178.3%) to their portfolio in Q3 2024, for an estimated $143,934,358
- STATE STREET CORP removed 1,529,870 shares (-18.6%) from their portfolio in Q3 2024, for an estimated $104,214,744
- ARMISTICE CAPITAL, LLC removed 1,400,086 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $95,373,858
- MACKENZIE FINANCIAL CORP added 1,393,917 shares (+12084.2%) to their portfolio in Q3 2024, for an estimated $94,953,626
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
